Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

The receptor tyrosine kinases (RTKs) are key drivers of cancer progression and targets for drug therapy. A major challenge in anti-RTK treatment is the dependence of drug effectiveness on co-expression of multiple RTKs which defines resistance to single drug therapy. Reprogramming of the RTK network...

Descripción completa

Detalles Bibliográficos
Autores principales: Goltsov, Alexey, Deeni, Yusuf, Khalil, Hilal S., Soininen, Tero, Kyriakidis, Stylianos, Hu, Huizhong, Langdon, Simon P., Harrison, David J., Bown, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092865/
https://www.ncbi.nlm.nih.gov/pubmed/24918976
http://dx.doi.org/10.3390/cells3020563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092865/
https://www.ncbi.nlm.nih.gov/pubmed/24918976
http://dx.doi.org/10.3390/cells3020563

Ejemplares similares